Jerry S. Lanchbury, Chief Scientific Officer at MYRIAD GENETICS INC (MYGN), sold 56,450 shares at $35.57 ($2.0M) on 2021-08-05, disclosed to the SEC on 2021-08-06.
Open-market sale of $2.0M MYGN by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.57 | 28,225 | $1.0M | 50.0% |
| 2 | $35.57 | 28,225 | $1.0M | 50.0% |
| Total | $35.57 avg | 56,450 | $2.0M | 100% |
| Filing → |
| MYGN | SELL | 2021-08-05 | $4.5M | — | Filing → |
| MYGN | SELL | 2021-07-14 | $4.9M | — | Filing → |
| MYGN | SELL | 2021-07-12 | $3.3M | — | Filing → |